Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Type III IFNs"'
Autor:
Anuradha Rajamanickam, Nathella Pavan Kumar, Arul Nancy Pandiaraj, Nandhini Selvaraj, Saravanan Munisankar, Rachel Mariam Renji, Vijayalakshmi Venkatramani, Manoj Murhekar, Jeromie Wesley Vivian Thangaraj, Muthusamy Santhosh Kumar, Chethrapilly Purushothaman Girish Kumar, Tarun Bhatnagar, Manickam Ponnaiah, Ramasamy Sabarinathan, Velusamy Saravanakumar, Subash Babu
Publikováno v:
BMC Immunology, Vol 23, Iss 1, Pp 1-8 (2022)
Abstract Background Plasmacytoid and myeloid dendritic cells play a vital role in the protection against viral infections. In COVID-19, there is an impairment of dendritic cell (DC) function and interferon secretion which has been correlated with dis
Externí odkaz:
https://doaj.org/article/3df44ab772b142d081670c52cd9bbe1c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ivan Zanoni, Charlotte Odendall
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Externí odkaz:
https://doaj.org/article/20cb8544594f4569b6b9c37eb9afb6f3
Autor:
Anuradha Rajamanickam, Saravanan Munisankar, Yukthi Bhootra, Chandrakumar Dolla, Thomas B. Nutman, Subash Babu
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Type III IFNs are important players in immunity to viral and bacterial infections. However, their association with helminth infections has not been examined. To explore the association of Type III IFNs with Strongyloides stercoralis (Ss) infection, w
Externí odkaz:
https://doaj.org/article/2305a5d6c1e84bfaa4b704023ccab415
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ghada M. Salum, Noha E. Ibrahim, Reham M. Dawood, Mai Abd El-Meguid, Mostafa K. El Awady, Ashraf O. Abdel Aziz
Publikováno v:
Genes & Diseases
Genes and Diseases, Vol 7, Iss 3, Pp 392-400 (2020)
Genes and Diseases, Vol 7, Iss 3, Pp 392-400 (2020)
In Egypt, Sofosbuvir (SOF) in combination with Dataclasvir (DCV) is the broadly used DAAs with excellent therapeutic profile. This study is designed to explore the relation between IL28B/TLR4 genetic variants and each of the followings; HCC developme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf5ea0bcfcc682cf6d56f80865444855
https://pubmed.ncbi.nlm.nih.gov/32884993
https://pubmed.ncbi.nlm.nih.gov/32884993
Autor:
Charlotte Odendall, Ivan Zanoni
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2dc5e6f2125ca33c2df294f97b6fa88b
http://hdl.handle.net/10281/255568
http://hdl.handle.net/10281/255568
Autor:
Yukthi Bhootra, Anuradha Rajamanickam, Thomas B. Nutman, Chandrakumar Dolla, Saravanan Munisankar, Subash Babu
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 9 (2018)
Frontiers in Immunology, Vol 9 (2018)
Type III IFNs are important players in immunity to viral and bacterial infections. However, their association with helminth infections has not been examined. To explore the association of Type III IFNs with Strongyloides stercoralis (Ss) infection, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdb172b06a55d4fb66dd2dd7b912b43b
http://europepmc.org/articles/PMC6205947
http://europepmc.org/articles/PMC6205947
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 8 (2017)
Frontiers in Immunology, Vol 8 (2017)
Type III interferons, also known as interferon lambdas (IFNλs), are the most recent addition to the IFN family following their discovery in 2003. Initially, IFNλ was demonstrated to induce expression of interferon-stimulated genes and exert antivir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::465b9b859556430068fd49c3b79f5c21
https://doi.org/10.3389/fimmu.2017.01707
https://doi.org/10.3389/fimmu.2017.01707